AFP and hepatocellular carcinoma: According to the risk stratification of HCC in patients with chronic liver disease, it is recommended to use abdominal ultrasound and serum AFP for routine surveillance, and multimodal MRI or CT enhanced surveillance are recommended for the high-risk population.